Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-07

FDA Approved: SORAFENIB — Original Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approves the original application for a generic sorafenib product from Dr. Reddy's Laboratories Inc, expanding access to the cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorafenib (Sorafenib)

Snippet

ORIG AP for SORAFENIB (SORAFENIB)